Inactive Instrument

Insiders PDL BioPharma, Inc.

Equities

PDLI

US69329Y1047

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

David W. Gryska to Resign as Member of the Board of Directors and Committee of PDL BioPharma, Inc., Effective December 31, 2020	20-12-08	CI
PDL BioPharma, Inc. Announces the Resignation of Shlomo Yanai from the Board of Directors	20-05-04	CI
PDL Biopharma, Inc. Appoints Edward A. Imbrogno as the Vice President and Chief Financial Officer	20-03-09	CI
PDL BioPharma, Inc. Appoints Alan L. Bazaar as Class III Director and Committee Member	20-02-28	CI
PDL BioPharma, Inc. Announces Board and Committee Changes	19-12-19	CI
PDL BioPharma, Inc. Announces Executive Changes	19-11-19	CI
PDL BioPharma, Inc. Announces resignation of Samuel R. Saks as a Member of the Board of Directors	19-08-29	CI
PDL BioPharma, Inc. Announces Resignation of Peter Garcia as Vice President and Chief Financial Officer, Effective as of August 15, 2019	19-06-25	CI
PDL BioPharma, Inc. Announces Management Appointments	19-06-24	CI
PDL BioPharma, Inc. Announces Resignation of Paul Edick as Member of the Board of Directors, Effective December 31, 2018	18-11-29	CI
PDL BioPharma, Inc. Announces Management Changes, Effective on December 31, 2018	18-11-06	CI
PDL BioPharma, Inc. Names Edward Imbrogno as Vice President of Finance	18-10-08	CI
PDL BioPharma, Inc. Announces Resignation of Jody Lindell as a Member of the Board of Directors	18-10-04	CI
PDL BioPharma : Elizabeth O'Farrell Named to PDL BioPharma's Board of Directors	18-06-22	PU
PDL BioPharma, Inc. Appoints Elizabeth G. O'farrell as a Class I Director and as a Member of the Board's Audit Committee	18-06-22	CI
PDL BioPharma, Inc. Elects Shlomo Yanai to the Board of Directors	18-06-11	CI
PDL BioPharma, Inc. Appoints Jill M. Jene, Ph.D. as Vice President, Business Development	18-05-21	CI
PDL BioPharma : Shareholder, SevenSaoi Capital, Comments on the Nomination of Shlomo Yanai to the PDL Board of Directors and Delivers Letter to the Board Outlining Significant Concerns	18-04-09	PR
Steffen Pietzke Tenders Resignation to PDL BioPharma, Inc. as Vice President, Finance and Chief Accounting Officer, Effective as of April 17, 2018	18-04-09	CI
PDL BioPharma Discloses Nomination Notice from SevenSaoi Capital	18-04-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders PDL BioPharma, Inc.

Equities

PDLI

US69329Y1047

Insiders

Filters